Best Practice for Early Stage VC Funding. Brian McVeigh, Doug Carlson, Mike Tusche

Our expert panel of hugley successful biotech C-leaders jump into best practices to ensure successful early fund raises in the biotech space.  Having raised 100's of millions of dollars between them this is a great listen for all of those joining the fundraising roadshow. 

Doug Carlson - Cheif Operating and Financial Officer - Avenge Bio 

Mike Tusche - Co-CEO - Treadwell Therapeutics  

Brian McVeigh - CEO - Code Biotherapeutics

Hosted by Jared Green and Alex Cooke from Phase 3 Search 

www.ph3.bio